<--- Back to Details
First PageDocument Content
Systemic risk / Financial markets / Self-regulatory organizations / Stock market / Commodity markets / Derivative / Commodity Futures Trading Commission / Swap Execution Facility / Over-the-counter / National Futures Association / Commodity Futures Modernization Act / Futures contract
Date: 2016-07-07 08:58:34
Systemic risk
Financial markets
Self-regulatory organizations
Stock market
Commodity markets
Derivative
Commodity Futures Trading Commission
Swap Execution Facility
Over-the-counter
National Futures Association
Commodity Futures Modernization Act
Futures contract

Derivatives: Introduction and Legislation in the 114th Congress

Add to Reading List

Source URL: www.fas.org

Download Document from Source Website

File Size: 1,01 MB

Share Document on Facebook

Similar Documents

Incentives to centrally clear over-the-counter (OTC) derivatives: A post-implementation evaluation of the effects of the G20 financial regulatory reforms

Incentives to centrally clear over-the-counter (OTC) derivatives: A post-implementation evaluation of the effects of the G20 financial regulatory reforms

DocID: 1xTGW - View Document

[723]  VOL. CCCXXIX OVER THE COUNTER SALES $2·75 INCLUDING G.S.T.

[723] VOL. CCCXXIX OVER THE COUNTER SALES $2·75 INCLUDING G.S.T.

DocID: 1vs3W - View Document

What do we mean by…? What do you mean by

What do we mean by…? What do you mean by "drug"? We define a drug as a substance people take to change the way they feel, think or behave. This term encompasses all prescribed and over-the-counter medicines, all legal

DocID: 1viqm - View Document

FDA revises restriction on over-the-counter access to Plan B emergency contraception to women 17 and over

FDA revises restriction on over-the-counter access to Plan B emergency contraception to women 17 and over

DocID: 1vekW - View Document

Maximal Usage Trials for Topical Active Ingredients Being Considered for Inclusion in an Over-The Counter Monograph: Study Elements and Considerations Guidance for Industry

Maximal Usage Trials for Topical Active Ingredients Being Considered for Inclusion in an Over-The Counter Monograph: Study Elements and Considerations Guidance for Industry

DocID: 1v9zy - View Document